dear bmitra,
surya pharma's earning for the past 4 or 5 quarters is around Rs.13 Crores each. Expecting the same to continue for this year also, the total earning for the year will work out to Rs.52 crores. the equity of the company is around Rs.14.5 crores. hence eps for the year will work out to about Rs.35/- per share and p/e ratio at Rs.105/- (market price) will be around 3. I expect it to move upto at least 5, which means the price may have to go at least to Rs.175/- by March 2010, if the same rate of earnings is maintained. (if not increased). further, book value of the scrip is also around Rs.159/-. hence i feel it is fundamentally a very strong script
surya pharma's earning for the past 4 or 5 quarters is around Rs.13 Crores each. Expecting the same to continue for this year also, the total earning for the year will work out to Rs.52 crores. the equity of the company is around Rs.14.5 crores. hence eps for the year will work out to about Rs.35/- per share and p/e ratio at Rs.105/- (market price) will be around 3. I expect it to move upto at least 5, which means the price may have to go at least to Rs.175/- by March 2010, if the same rate of earnings is maintained. (if not increased). further, book value of the scrip is also around Rs.159/-. hence i feel it is fundamentally a very strong script
